(Q46197560)

20 December 2017

title

Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer (English)

1 reference

20 December 2017

1 reference

Scott M Eisenkop

1

1 reference

20 December 2017

Nick M Spirtos

series ordinal

2

1 reference

20 December 2017

Wei-Chien Michael Lin

series ordinal

3

1 reference

20 December 2017

language of work or name

English

0 references

publication date

3 October 2005

1 reference

20 December 2017

published in

Gynecologic Oncology

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

344-348

1 reference

20 December 2017

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Primary surgical therapy of ovarian cancer: how much and when

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

The effect of bowel resection on survival in advanced epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Future directions in the surgical management of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

A critique of surgical cytoreduction in advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Electrosurgical debulking of ovarian cancer: a new technique using the argon beam coagulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

The cavitational ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Loop electrosurgical excision procedure for intensified cytoreduction of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Splenectomy and surgical cytoreduction for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Splenectomy in recurrent epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

Solitary recurrent metastasis of epithelial ovarian cancer in the spleen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.036

10.1016/J.YGYNO.2005.08.036

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017